IRC Section 280E creates significant financial barriers for cannabis businesses, including medical cannabis dispensaries and clinics, by disallowing standard business deductions. These tax burdens can impact patient access through higher prices and reduced availability of medical cannabis services.
IRC Section 280E prohibits businesses trafficking in controlled substances from deducting ordinary business expenses, creating effective tax rates that can exceed 70% for cannabis operations. This applies to medical cannabis businesses despite state legalization, as cannabis remains federally scheduled. The tax burden affects operational sustainability and pricing structures across the medical cannabis supply chain.
“As a clinician, I see how 280E indirectly impacts my patients through reduced dispensary options and higher product costs. The tax code shouldn’t be the primary barrier between patients and their medicine.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
Table of Contents
FAQ
What is the clinical relevance rating of this cannabis news?
This article has been assigned CED Clinical Relevance #70, indicating “Notable Clinical Interest.” This rating suggests the content contains emerging findings or policy developments that healthcare professionals should monitor closely.
What main topics does this cannabis news cover?
The article covers policy, access, economics, and medical cannabis topics. These categories indicate the news likely discusses regulatory changes, patient access issues, economic implications, and clinical applications of cannabis.
Who is the source of this cannabis news?
This news comes from CED Clinic, a source that appears to specialize in cannabis-related clinical and policy information. The content is categorized under their cannabis news section.
Why is this considered “notable clinical interest”?
The “notable clinical interest” designation means this news contains information that could impact clinical practice or patient care. It represents emerging developments that healthcare providers should be aware of for potential future implications.
What does the “New” designation indicate?
The “New” label indicates this is recently published or updated information. This suggests the content contains fresh developments in cannabis policy, access, or medical applications that have recently emerged.